Here's your quick look at what's coming in August 2024.
Blair Anderson
Founder & Recruiter | Medical Device Senior Appointments | Regulatory Affairs | Startups - SMBs | Executive & Commercial Specialist | Passionate Golfer & Devoted Dog Lover
August 6, 2024: ?FDA Public Virtual Workshop to Consider Artificial Intelligence in Drug and Biological Product Development
This public workshop will convene AI experts, including drug sponsors, academia, and technology organizations, to discuss guiding principles that innovators apply to promote AI's responsible use in developing safe and effective drugs. Topics for Discussion at the Workshop
At this public workshop, the FDA plans to convene experts in AI to discuss topics including but not limited to:
August 7, 2024: Medical Device Sterilization Town Hall: Sterilization Short Topics and Open Q&A
This is the tenth townhall in the sterilization series.? During this town hall, the FDA will host topics including bioburden, bacterial endotoxin, and packaging integrity testing for sterile medical devices.
领英推荐
August 21, 2024: 11th Annual UGA-FDA Medical Device Regulations Virtual Conference
Conference Objectives
To share knowledge and exchange information about the concepts of regulatory compliance to advance product quality and efficacy by assuring patient benefit.
Enable participants to gain insights into emerging regulatory trends and requirements shaping the medical device industry.
Educate attendees on navigating regulatory compliance requirements essential for medical devices in the market.
Conference Topics:
August 22, 2024: Webinar - In Vitro Diagnostic Products (IVDs) - MDR Requirements, Correction and Removal Reporting Requirements, and Quality System Complaint Requirements
This webinar is intended for laboratory manufacturers and other interested stakeholders to discuss how to comply with medical device reporting (MDR) requirements, correction and removal reporting requirements, and quality system (QS) requirements regarding complaint files beginning May 6, 2025 (Stage 1 of the phaseout policy).